- Policy
- COVID vaccine side effects proven by the Government
- by Kim, Jung-Ju Nov 24, 2022 05:50am
- In order to prevent new infectious diseases such as COVID-19, a revision to the related law will be promoted to allow the government to receive medical and nursing expenses first if it is damaged by side effects after being vaccinated. Chung Chun-sook, a member of the Democratic Party of Korea's Health and Welfare Committee, proposed today (2
- Policy
- The government are in full swing discussing support
- by Lee, Jeong-Hwan Nov 24, 2022 05:50am
- The ruling party and the government's move to expand access to patients with severe and rare diseases, which was President Yoon Suk Yeol's presidential pledge, is notable. On the 21st, the People's Power, the Ministry of Health and Welfare, and the Ministry of Strategy and Finance will hold a policy meeting at the National Assembly to prepare
- Policy
- Gov’t to increase drug price reference countries
- by Lee, Tak-Sun Nov 23, 2022 06:04am
- The Health Insurance Review and Assessment Service made a preannouncement of a revision plan to expand the number of reference countries used to evaluate new drugs from 7 to 9 (US, UK, Germany, France, Italy, Switzerland, Japan, Canada, Australia·A9). After opinion inquiries, the revised plan will take effect in January next year. Althou
- Policy
- MFDS recruits companies to develop 6 National Essential Drug
- by Lee, Hye-Kyung Nov 23, 2022 06:04am
- The government is busy recruiting institutions to develop domestic manufacturing technology for items that are heavily dependent on imports and have unstable supply to achieve self-sufficiency of national essential medicines. The Ministry of Food and Drug Safety had recently selected 11 products, including 5 raw materials and 6 finished prod
- Policy
- Forxiga Prodrug will be reimbursed for five months
- by Lee, Tak-Sun Nov 23, 2022 06:04am
- Prodrug of Forxiga, an SGLT-2 diabetes treatment drug that Dong-A ST succeeded in avoiding patents through the development of drugs, will be listed on the 1st of next month. It is five months before the expiration of the patent. Earlier this month, it was possible because it succeeded in avoiding the duration of the material patent, which end
- Policy
- Reimb standards will be newly established for Coagadex
- by Kim, Jung-Ju Nov 22, 2022 06:04am
- Reimbursement standards for the hemophilia treatment Coagadex (Human coagulation factor X) that had been granted urgent introduction in Korea have been newly established. Also, oral eperisone hydrochloride as well as oral and ophthalmic solutions that include syrup and oral suspension forms of sodium alginate that were subject to reevalua
- Policy
- Phase 3 of Fitusiran, an all-around tx for hemophilia
- by Lee, Hye-Kyung Nov 22, 2022 06:04am
- Phase 3 clinical trials of Fitusiran, a treatment candidate substance that is effective for both hemophilia A and B, are also being conducted in Korea. The Ministry of Food and Drug Safety approved a phase 3 clinical trial of Sanofi-Aventis Korea on the 18th. This clinical trial is a phase 3, single group, multi-organ, multinational clinical
- Policy
- Gov't declines preferential pricing for innovative drugs
- by Lee, Jeong-Hwan Nov 21, 2022 05:56am
- Complaints are rising in various areas of the pharmaceutical industry with the Ministry of Health and Welfare maintaining its position that preferential pricing for new drugs manufactured by Korea Innovative Pharmaceutical Companies cannot be introduced in practicality due to issues including trade conflict, NHI finances, etc. The indust
- Policy
- Label for rosuvastatin to change following ticagrelor
- by Lee, Hye-Kyung Nov 21, 2022 05:56am
- The drug-drug interaction label for rosuvastatin drugs that are used to treat hyperlipidemia including AstraZeneca’s ‘Crestor’ will be changed. The drugs that affect rosuvastatin are ticagrelor drugs including AstraZeneca’s antiplatelet drug ‘Brilinta.’ The labeling change for ticagrelor has been preannounced by the Ministry of Foo
- Policy
- Public policy fee for severely ill children is implemented
- by Kim, Jung-Ju Nov 21, 2022 05:56am
- The government will push for a pilot project for a new payment system for the sustainability of treatment for severely ill children and adolescents. The Ministry of Health and Welfare (Minister Cho Kyu-hong) announced that it will recruit participating institutions for about four weeks from today (17th) to December 15th, which will take effec
